Cochrane Collaborative Review Group on Peripheral Vascular Diseases: Review Abstracts  by unknown
Eur J Vasc Endovasc Surg 18, 4–5 (1999)
Article No. ejvs.1999.0897
COCHRANE REVIEWS
Cochrane Collaborative Review Group on Peripheral Vascular Diseases:
Review Abstracts
Introduction Department of Clinical Neurosciences
Western General Hospital
Crewe RoadThe following abstracts are part of an ongoing quar-
Edinburgh EH4 2XUterly series of articles produced by the Cochrane Col-
Tel. +44 (0) 131 537 2273laborative Review Group on Peripheral Vascular
Fax. +44 (0) 131 332 5150Diseases. This issue, the abstracts published come from
reviews produced by another group with a major
Any comments or criticisms on Cochrane reviews/vascular surgical component, the Cochrane Stroke
abstracts should be made through the comments/Group.
criticisms facility on the Cochrane Library, or by con-The reviews are published in full on the Cochrane
tacting the group at the above addresses.Library, a quarterly electronic journal available on CD-
ROM, the Internet and many health care libraries.
This electronic format allows Cochrane reviews to
accommodate new data as they become available,
Abstractsmaking the library a consistently up-to-date source of
information over time.
Abstract: Percutaneous transluminal angioplasty andIn future, review abstracts appearing on the Co-
stenting for vertebral artery stenosischrane Library will be presented in a different, sim-
F. Crawley and M. M. Brownplified format to permit greater accessibility to the
Date of most recent substantive amendment: 8 May 1997public. However, Cochrane review abstracts published
in the European Journal of Vascular and Endovascular Objectives
Surgery will be presented in the more traditional To determine if vertebral artery percutaneous trans-
journal style. Review abstracts on Cochrane reviews luminal angioplasty (PTA) is safe and effective com-
will also be indexed on Medline in the very near pared to medical treatment alone for patients with
future. symptomatic vertebrobasilar artery disease.
If you are interested in writing a Cochrane review
or becoming a member of either group please contact: Search strategy
Cochrane Stroke Group Specialised Register and per-
Professor F. G. R. Fowkes sonal contact with experts in the field.
Cochrane Collaborative Review Group on
Peripheral Vascular Disease Selection criteria
Public Health Sciences All truly randomised unconfounded controlled clinical
University of Edinburgh trials comparing best medical therapy plus vertebral
Teviot Place PTA (with or without stenting) with best medical
Edinburgh EH8 9AG therapy alone in patients with symptomatic vertebral
Tel. +44 (0) 131 650 3220 artery stenosis.
Fax. +44 (0) 131 650 6904
or Data collection and analysis
Dr Peter Sandercock Two reviewers independently selected trials for in-
clusion and extracted the relevant data. The followingCochrane Stroke Group
1078–5884/99/070004+02 $12.00/0 Ó 1999 W.B. Saunders Company Ltd.
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outcomes were assessed: death, vertebrobasilar stroke, Search strategy
Cochrane Stroke Group Specialised Register and per-any stroke, restenosis, and other complications.
sonal contact with experts in the field.
Main results
Selection criteriaNo completed RCTs have been identified. There is one
All randomised controlled clinical trials comparingongoing trial of carotid and vertebral PTA but few
carotid PTA (with or without stenting) with carotidpatients with vertebrobasilar disease have been re-
endarterectomy or trials comparing carotid PTA andcruited.
best medical therapy versus best medical therapy in
patients with symptomatic or asymptomatic carotidConclusions
artery stenosis.There is no evidence yet to support the use of routine
PTA for vertebral artery stenosis. In general vertebral Data collection and analysis
artery PTA should only be performed in the context Two reviewers independently selected trials for in-
of a randomised controlled trial. clusion and extracted the relevant data. The following
outcomes were assessed: death, stroke ipsilateral to
the procedure, any stroke, restenosis, and other com-
plications.
Main results
Abstract: Percutaneous transluminal angioplasty and No completed RCTs have been identified as yet. One
stenting for carotid artery stenosis trial has finished randomising but is not analysed, and
F. Crawley and M. M. Brown one is ongoing.
Date of most recent substantive amendment: 21 July 1997
Conclusions
There is no evidence as yet to support a change inObjectives
To determine whether carotid percutaneous trans- the routine clinical treatment of patients with carotid
stenosis to PTA with or without stenting. However, theluminal angioplasty (PTA) is safer and yet equally as
effective as carotid endarterectomy in patients suitable data support the continuing randomisation of patients
within clinical trials between PTA and conventionalfor surgery, or is more effective than medical therapy
in patients not suitable for surgery. treatment.
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